HEADER CELL ADHESION 04-JAN-08 2VKW TITLE HUMAN NCAM, FN3 DOMAINS 1 AND 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: NEURAL CELL ADHESION MOLECULE 1,140 KDA ISOFORM; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: FN3 DOMAINS, RESIDUES 496-598,601-692; COMPND 5 SYNONYM: N-CAM 140, NCAM-140, CD56 ANTIGEN, NEURAL CELL ADHESION COMPND 6 MOLECULE; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 6 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: 293-EBNA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PCEP-PU KEYWDS ADHESION RECEPTOR, CELL ADHESION EXPDTA X-RAY DIFFRACTION AUTHOR F.CARAFOLI,J.L.SAFFELL,E.HOHENESTER REVDAT 5 08-MAY-24 2VKW 1 REMARK REVDAT 4 08-NOV-17 2VKW 1 SOURCE REVDAT 3 24-FEB-09 2VKW 1 VERSN REVDAT 2 18-MAR-08 2VKW 1 JRNL REVDAT 1 26-FEB-08 2VKW 0 JRNL AUTH F.CARAFOLI,J.L.SAFFELL,E.HOHENESTER JRNL TITL STRUCTURE OF THE TANDEM FIBRONECTIN TYPE 3 DOMAINS OF NEURAL JRNL TITL 2 CELL ADHESION MOLECULE JRNL REF J.MOL.BIOL. V. 377 524 2008 JRNL REFN ISSN 0022-2836 JRNL PMID 18261743 JRNL DOI 10.1016/J.JMB.2008.01.030 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 10000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 16920 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.218 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1691 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3058 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 25 REMARK 3 SOLVENT ATOMS : 98 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.76900 REMARK 3 B22 (A**2) : -0.08400 REMARK 3 B33 (A**2) : -1.68400 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.330 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.250 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.100 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.320 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : 0.45 REMARK 3 BSOL : 38.39 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2VKW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 04-JAN-08. REMARK 100 THE DEPOSITION ID IS D_1290034906. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.49 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16957 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.800 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.80 REMARK 200 R MERGE FOR SHELL (I) : 0.12000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 11.10 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: AUTOSHARP REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.28 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.08 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 5.2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 26.38500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 49.10850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.67300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 49.10850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.38500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 35.67300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 3310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.8 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 492 REMARK 465 PRO A 493 REMARK 465 LEU A 494 REMARK 465 ALA A 495 REMARK 465 ALA A 694 REMARK 465 HIS A 695 REMARK 465 HIS A 696 REMARK 465 HIS A 697 REMARK 465 HIS A 698 REMARK 465 HIS A 699 REMARK 465 HIS A 700 REMARK 465 ALA B 492 REMARK 465 PRO B 493 REMARK 465 LEU B 494 REMARK 465 ALA B 495 REMARK 465 GLN B 496 REMARK 465 ALA B 693 REMARK 465 ALA B 694 REMARK 465 HIS B 695 REMARK 465 HIS B 696 REMARK 465 HIS B 697 REMARK 465 HIS B 698 REMARK 465 HIS B 699 REMARK 465 HIS B 700 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ALA A 693 CA C O CB REMARK 470 ALA B 692 CA C O CB REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 511 -150.99 -121.51 REMARK 500 ARG A 599 -158.65 -152.73 REMARK 500 TYR B 511 -148.41 -119.32 REMARK 500 ASN B 615 49.70 -93.48 REMARK 500 HIS B 633 164.94 177.65 REMARK 500 SER B 643 -165.73 -125.02 REMARK 500 ASN B 677 -168.39 -123.25 REMARK 500 THR B 691 -174.35 -66.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B1692 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B1693 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A1693 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B1694 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 B1695 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2VKX RELATED DB: PDB REMARK 900 HUMAN NCAM, FN3 DOMAINS 1 AND 2, M610R MUTANT REMARK 999 REMARK 999 SEQUENCE REMARK 999 N-TERMINAL APLA AND C-TERMINAL AAAHHHHHH ARE VECTOR- REMARK 999 DERIVED. QG (POSITIONS 599-600) OF P13591 REPLACED BY R ( REMARK 999 NATURAL MUSCLE- AND BRAIN-SPECIFIC SPLICE VARIANT) DBREF 2VKW A 492 495 PDB 2VKW 2VKW 492 495 DBREF 2VKW A 496 598 UNP P13591 NCA11_HUMAN 496 598 DBREF 2VKW A 599 599 PDB 2VKW 2VKW 599 599 DBREF 2VKW A 600 691 UNP P13591 NCA11_HUMAN 601 692 DBREF 2VKW A 692 700 PDB 2VKW 2VKW 692 700 DBREF 2VKW B 492 495 PDB 2VKW 2VKW 492 495 DBREF 2VKW B 496 598 UNP P13591 NCA11_HUMAN 496 598 DBREF 2VKW B 599 599 PDB 2VKW 2VKW 599 599 DBREF 2VKW B 600 691 UNP P13591 NCA11_HUMAN 601 692 DBREF 2VKW B 692 700 PDB 2VKW 2VKW 692 700 SEQRES 1 A 209 ALA PRO LEU ALA GLN ALA ASP THR PRO SER SER PRO SER SEQRES 2 A 209 ILE ASP GLN VAL GLU PRO TYR SER SER THR ALA GLN VAL SEQRES 3 A 209 GLN PHE ASP GLU PRO GLU ALA THR GLY GLY VAL PRO ILE SEQRES 4 A 209 LEU LYS TYR LYS ALA GLU TRP ARG ALA VAL GLY GLU GLU SEQRES 5 A 209 VAL TRP HIS SER LYS TRP TYR ASP ALA LYS GLU ALA SER SEQRES 6 A 209 MET GLU GLY ILE VAL THR ILE VAL GLY LEU LYS PRO GLU SEQRES 7 A 209 THR THR TYR ALA VAL ARG LEU ALA ALA LEU ASN GLY LYS SEQRES 8 A 209 GLY LEU GLY GLU ILE SER ALA ALA SER GLU PHE LYS THR SEQRES 9 A 209 GLN PRO VAL ARG GLU PRO SER ALA PRO LYS LEU GLU GLY SEQRES 10 A 209 GLN MET GLY GLU ASP GLY ASN SER ILE LYS VAL ASN LEU SEQRES 11 A 209 ILE LYS GLN ASP ASP GLY GLY SER PRO ILE ARG HIS TYR SEQRES 12 A 209 LEU VAL ARG TYR ARG ALA LEU SER SER GLU TRP LYS PRO SEQRES 13 A 209 GLU ILE ARG LEU PRO SER GLY SER ASP HIS VAL MET LEU SEQRES 14 A 209 LYS SER LEU ASP TRP ASN ALA GLU TYR GLU VAL TYR VAL SEQRES 15 A 209 VAL ALA GLU ASN GLN GLN GLY LYS SER LYS ALA ALA HIS SEQRES 16 A 209 PHE VAL PHE ARG THR ALA ALA ALA HIS HIS HIS HIS HIS SEQRES 17 A 209 HIS SEQRES 1 B 209 ALA PRO LEU ALA GLN ALA ASP THR PRO SER SER PRO SER SEQRES 2 B 209 ILE ASP GLN VAL GLU PRO TYR SER SER THR ALA GLN VAL SEQRES 3 B 209 GLN PHE ASP GLU PRO GLU ALA THR GLY GLY VAL PRO ILE SEQRES 4 B 209 LEU LYS TYR LYS ALA GLU TRP ARG ALA VAL GLY GLU GLU SEQRES 5 B 209 VAL TRP HIS SER LYS TRP TYR ASP ALA LYS GLU ALA SER SEQRES 6 B 209 MET GLU GLY ILE VAL THR ILE VAL GLY LEU LYS PRO GLU SEQRES 7 B 209 THR THR TYR ALA VAL ARG LEU ALA ALA LEU ASN GLY LYS SEQRES 8 B 209 GLY LEU GLY GLU ILE SER ALA ALA SER GLU PHE LYS THR SEQRES 9 B 209 GLN PRO VAL ARG GLU PRO SER ALA PRO LYS LEU GLU GLY SEQRES 10 B 209 GLN MET GLY GLU ASP GLY ASN SER ILE LYS VAL ASN LEU SEQRES 11 B 209 ILE LYS GLN ASP ASP GLY GLY SER PRO ILE ARG HIS TYR SEQRES 12 B 209 LEU VAL ARG TYR ARG ALA LEU SER SER GLU TRP LYS PRO SEQRES 13 B 209 GLU ILE ARG LEU PRO SER GLY SER ASP HIS VAL MET LEU SEQRES 14 B 209 LYS SER LEU ASP TRP ASN ALA GLU TYR GLU VAL TYR VAL SEQRES 15 B 209 VAL ALA GLU ASN GLN GLN GLY LYS SER LYS ALA ALA HIS SEQRES 16 B 209 PHE VAL PHE ARG THR ALA ALA ALA HIS HIS HIS HIS HIS SEQRES 17 B 209 HIS HET SO4 A1693 5 HET SO4 B1692 5 HET SO4 B1693 5 HET SO4 B1694 5 HET SO4 B1695 5 HETNAM SO4 SULFATE ION FORMUL 3 SO4 5(O4 S 2-) FORMUL 8 HOH *98(H2 O) HELIX 1 1 ALA A 552 GLY A 559 1 8 HELIX 2 2 ALA B 552 GLY B 559 1 8 SHEET 1 AA 3 SER A 504 PRO A 510 0 SHEET 2 AA 3 ALA A 515 ASP A 520 -1 O GLN A 516 N GLU A 509 SHEET 3 AA 3 ILE A 560 ILE A 563 -1 O VAL A 561 N VAL A 517 SHEET 1 AB 4 HIS A 546 ASP A 551 0 SHEET 2 AB 4 LYS A 532 ALA A 539 -1 O TYR A 533 N TYR A 550 SHEET 3 AB 4 THR A 571 ASN A 580 -1 O ALA A 573 N ARG A 538 SHEET 4 AB 4 SER A 591 LYS A 594 -1 O SER A 591 N VAL A 574 SHEET 1 AC 4 HIS A 546 ASP A 551 0 SHEET 2 AC 4 LYS A 532 ALA A 539 -1 O TYR A 533 N TYR A 550 SHEET 3 AC 4 THR A 571 ASN A 580 -1 O ALA A 573 N ARG A 538 SHEET 4 AC 4 GLY A 583 LEU A 584 -1 O GLY A 583 N ASN A 580 SHEET 1 AD 3 LYS A 605 MET A 610 0 SHEET 2 AD 3 ILE A 617 ILE A 622 -1 O LYS A 618 N GLN A 609 SHEET 3 AD 3 HIS A 657 LEU A 660 -1 O VAL A 658 N VAL A 619 SHEET 1 AE 7 ILE A 649 LEU A 651 0 SHEET 2 AE 7 HIS A 633 ALA A 640 -1 O TYR A 634 N LEU A 651 SHEET 3 AE 7 GLU A 668 ASN A 677 -1 O GLU A 670 N ARG A 639 SHEET 4 AE 7 ALA A 685 ARG A 690 -1 O ALA A 685 N VAL A 673 SHEET 5 AE 7 LYS B 605 MET B 610 1 O LEU B 606 N VAL A 688 SHEET 6 AE 7 ILE B 617 ILE B 622 -1 O LYS B 618 N GLN B 609 SHEET 7 AE 7 HIS B 657 LEU B 660 -1 O VAL B 658 N VAL B 619 SHEET 1 AF 4 ILE A 649 LEU A 651 0 SHEET 2 AF 4 HIS A 633 ALA A 640 -1 O TYR A 634 N LEU A 651 SHEET 3 AF 4 GLU A 668 ASN A 677 -1 O GLU A 670 N ARG A 639 SHEET 4 AF 4 GLY A 680 LYS A 681 -1 O GLY A 680 N ASN A 677 SHEET 1 BA 3 SER B 504 PRO B 510 0 SHEET 2 BA 3 ALA B 515 ASP B 520 -1 O GLN B 516 N GLU B 509 SHEET 3 BA 3 VAL B 561 ILE B 563 -1 O VAL B 561 N VAL B 517 SHEET 1 BB 4 HIS B 546 ASP B 551 0 SHEET 2 BB 4 ILE B 530 ALA B 539 -1 O TYR B 533 N TYR B 550 SHEET 3 BB 4 THR B 571 ASN B 580 -1 O ALA B 573 N ARG B 538 SHEET 4 BB 4 SER B 591 LYS B 594 -1 O SER B 591 N VAL B 574 SHEET 1 BC 4 HIS B 546 ASP B 551 0 SHEET 2 BC 4 ILE B 530 ALA B 539 -1 O TYR B 533 N TYR B 550 SHEET 3 BC 4 THR B 571 ASN B 580 -1 O ALA B 573 N ARG B 538 SHEET 4 BC 4 GLY B 583 LEU B 584 -1 O GLY B 583 N ASN B 580 SHEET 1 BD 4 ILE B 649 PRO B 652 0 SHEET 2 BD 4 ILE B 631 ALA B 640 -1 O TYR B 634 N LEU B 651 SHEET 3 BD 4 GLU B 668 ASN B 677 -1 O GLU B 670 N ARG B 639 SHEET 4 BD 4 ALA B 685 ARG B 690 -1 O ALA B 685 N VAL B 673 SITE 1 AC1 7 LYS A 534 TRP A 549 ARG A 639 LYS B 532 SITE 2 AC1 7 ASP B 551 HOH B2044 HOH B2045 SITE 1 AC2 6 LYS A 548 TRP A 549 LYS B 548 TRP B 549 SITE 2 AC2 6 HOH B2046 HOH B2047 SITE 1 AC3 5 LYS A 532 ASP A 551 HOH A2051 TRP B 549 SITE 2 AC3 5 ARG B 639 SITE 1 AC4 1 ARG B 637 SITE 1 AC5 2 HIS B 546 SER B 547 CRYST1 52.770 71.346 98.217 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018950 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014016 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010182 0.00000 MTRIX1 1 -0.711740 0.701500 0.036370 42.05063 1 MTRIX2 1 0.702440 0.710990 0.032850 -17.72883 1 MTRIX3 1 -0.002820 0.048930 -0.998800 21.91621 1